[1] 施伟伟,花志祥,黄红娟,等. DPL结合羟氯喹治疗对玫瑰痤疮患者疗效和红斑血管扩张评分的影响及患者生活质量指数影响因素Logistic分析[J].中国美容医学,2021,(8):63-67.
  SHI Wei-wei,HUA Zhi-xiang,HUANG Hong-juan,et al. The Effect of DPL Combined with Hydroxychloroquine on Rosacea Patients’ Efficacy,Erythema Vasodilation Score and the Logistic Analysis of Influencing Factors ofQuality of Life Index in Patients[J].Medical Aesthetics and Beauty,2021,(8):63-67.
点击复制

 DPL结合羟氯喹治疗对玫瑰痤疮患者疗效和红斑血管扩张评分的影响及患
者生活质量指数影响因素Logistic分析
()
分享到:

《中国美容医学》[ISSN:1008-6445/CN:61-1347/R]

卷:
期数:
2021年8期
页码:
63-67
栏目:
出版日期:
2021-08-10

文章信息/Info

Title:
 The Effect of DPL Combined with Hydroxychloroquine on Rosacea Patients’ Efficacy,
Erythema Vasodilation Score and the Logistic Analysis of Influencing Factors of
Quality of Life Index in Patients
文章编号:
1008-6455(2021)08-0063-05
作者:
 施伟伟花志祥黄红娟范向华
Author(s):
 SHI Wei-weiHUA Zhi-xiangHUANG Hong-juanFAN Xiang-hua
关键词:
 [关键词]窄谱强脉冲光羟氯喹玫瑰痤疮红斑血管扩张评分生活质量指数
Keywords:
 Key words: narrow-spectrum intense pulsed light hydroxychloroquine rosacea erythema vasodilation score quality of lifeindex
分类号:
R758.73+4
文献标志码:
A
摘要:
[摘要]目的:研究窄谱强脉冲光(DPL)结合羟氯喹用药对玫瑰痤疮患者疗效和红斑血管扩张评分的影响,Logistic分析生活
质量指数影响因素。方法:选取笔者医院2017年6月-2019年6月收治的67例玫瑰痤疮患者,依据随机数字表法分为对照组
(n =33)以及观察组(n =34)。对照组采用羟氯喹治疗,观察组采用DPL结合羟氯喹治疗。比较两组患者临床疗效以及红斑
血管扩张评分和皮肤病生活质量指数(DLQI),并采用Logistic分析患者生活质量指数影响因素。结果:治疗后,两组患者
的红斑毛细血管扩张、丘疹脓疱、瘙痒评分均显著降低,其中观察组治疗后各评分显著低于对照组,且观察组治疗有效率显
著高于对照组(91.18% vs 69.70%),差异具有统计学意义(P <0.05)。治疗后,两组患者DLQI评分均显著降低,其中观察组
治疗后不同时间点(4周、8周、12周)各评分显著低于对照组,差异有统计学意义(P <0.05)。单因素分析显示,女性DLQI
评分高于男性,低年龄(≤30岁)患者DLQI评分高于高年龄患者(>30岁),未婚患者高于已婚患者,丘疹型患者高于红斑
型患者,差异具有统计学意义(P <0.05)。Logistic回归分析表明显示,性别、年龄、婚姻情况以及分型均是影响患者生活
质量的危险因素(P <0.05)。结论:DPL结合羟氯喹可有效降低红斑血管扩张评分,改善患者生活质量,提高治疗效果。性
别、年龄、婚姻情况以及分型均是影响玫瑰痤疮患者生活质量的危险因素。

Abstract:
Abstract: Objective To study the effect of DPL combined with hydroxychloroquine on rosacea patients’ efficacy and erythema
vasodilation score, and to analyze the influencing factors of quality of life index by Logistic. Methods 67 patients with rosacea
admitted to our hospital from June 2017 to June 2019 were divided into control group (33 cases) and observation group (34
cases) according to the method of random number table. The control group was treated with hydroxychloroquine, and the
observation group was treated with DPL and hydroxychloroquine. The clinical efficacy, erythema vasodilation score and skin
disease quality of life index (DLQI) were compared between the two groups, and the influencing factors of DLQI were analyzed
by Logistic. Results After treatment, the scores of capillaries dilation, pimples and pustules, pruritus in the two groups were
significantly reduced, and the scores in the observation group were significantly lower than those in the control group, and
the effective rate in the observation group was significantly higher than that in the control group (91.18% vs 69.70%), with
significant difference (P <0.05). After treatment, the DLQI scores of the two groups were significantly reduced, and the scores
of the observation group at different time points (4 weeks, 8 weeks, 12 weeks) were significantly lower than those of the control
group, with significant difference (P <0.05). Single factor analysis showed that the DLQI score of female patients was higher
than that of male patients, the DLQI score of patients with low age (<30 years old) was higher than that of patients with high
age (>30 years old), that of unmarried patients was higher than that of married patients, and that of patients with papule type
was higher than that of patients with erythema type (P <0.05). Logistic regression analysis showed that gender, age, marriage
and classification were all risk factors for quality of life (P <0.05). Conclusion Sex,age, marriage and classification are all risk
factors of rosacea patients’ quality of life. DPL combined with hydroxychloroquine can effectively reduce the score of erythema
vasodilation, improve the quality of life of patients, and improve the treatment effect.

相似文献/References:

[1] 潘廷猛,陈雪路,施 雯,等. 羟氯喹联合多西环素序贯光电协同治疗I型及Ⅱ型玫瑰痤疮临床观察[J].中国美容医学,2020,(9):22.
  PAN Ting-meng,CHEN Xue-lu,SHI Wen,et al. Clinical Observation on the Sequential Photoelectric Treatment of Rosacea Type Iand Type II with Hydroxychloroquine and Doxycycline[J].Medical Aesthetics and Beauty,2020,(8):22.
[2] 宗淑芳,刘 霞,丁小杰,等. 毫火针联合羟氯喹治疗玫瑰痤疮临床观察[J].中国美容医学,2020,(10):157.
  ZONG Shu-fang,LIU Xia,DING Xiao-jie,et al. Clinical Observation on the Treatment of Rosacea with Milli-fire Needle andHydroxychloroquine[J].Medical Aesthetics and Beauty,2020,(8):157.
[3]刘 萍,姚 倩,徐 琳,等.裸花紫珠片结合羟氯喹治疗红斑毛细血管扩张型玫瑰痤疮疗效分析[J].中国美容医学,2023,(4):88.
 LIU Ping,YAO Qian,XU Lin,et al.Effi cacy Analysis of Luohuazizhu Tablet Combined with Hydroxychloroquine in the Treatment of Erythema Capillary Dilated Rosacea[J].Medical Aesthetics and Beauty,2023,(8):88.
[4]来文兵,景海霞,唐吉云.精准脉冲光联合羟氯喹治疗红斑毛细血管扩张型玫瑰痤疮疗效观察[J].中国美容医学,2023,(4):104.
 LAI Wenbing,JING Haixia,TANG Jiyun.Clinical Observation of Delicate Pulsed Light Combined with Hydroxychloroquine in the Treatment of Erythematotelangiectatic Rosacea[J].Medical Aesthetics and Beauty,2023,(8):104.
[5]马 红,刘莉萍,李遇梅.羟氯喹治疗玫瑰痤疮的疗效和安全性系统评价[J].中国美容医学,2024,(4):70.
 MA Hong,LIU Liping,LI Yumei.Effi cacy and Safety of Hydroxychloroquine for Acne Rosacea : A Systematic Review[J].Medical Aesthetics and Beauty,2024,(8):70.

更新日期/Last Update: 2021-09-07